Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atea Pharmaceuticals, Inc. - common stock (NQ:AVIR)

4.580 -0.020 (-0.43%)
Streaming Delayed Price Updated: 2:22 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atea Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance ↗
Following the market opening Tuesday, the Dow traded up 0.29% to 35,361.89 while the NASDAQ rose 0.31% to 15,068.75. The S&P also rose, gaining 0.39% to 4,503.81. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $... 
Via Benzinga
News headline image
Why Are Atea Pharmaceuticals Shares Plunging Today? ↗
Atea Pharmaceuticals Inc (NASDAQ: AVIR) has reported data from the Phase 2 MOONSONG trial of AT-527 in the outpatient setting in patients with mild or moderate... 
Via Benzinga
News headline image
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage ↗
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral... 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies ↗
Companies working on sorely needed Covid treatments are innovating to keep up. 
Via Investor's Business Daily
News headline image
3 COVID Stocks That Can Turn $1,000 Into $10,000 ↗
Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic. 
Via The Motley Fool
News headline image
Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means ↗
Photo by Martin Sanchez on Unsplash Merck (NYSE: MRK) announced last Friday impressive results from its COVID-19 antiviral, molnupiravir. As vaccines are requiring a third booster... 
Via Benzinga
News headline image
10 Health Care Stocks With Unusual Options Alerts In Today's Session ↗
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021 ↗
Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ: 
Via Benzinga
News headline image
Which COVID-19 Pill Stock Is the Best Buy? ↗
Merck, Pfizer, and Atea are set to do battle next year in the COVID-19 pill market. 
Via The Motley Fool
News headline image
3 Stocks That Might Soar With Pills for COVID ↗
Are we seeing a major shift into oral medications for COVID? Our Foolish roundtable picks three of the strongest stocks in this rising subsector. 
Via The Motley Fool
News headline image
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher ↗
Toward the end of trading Friday, the Dow traded up 1.49% to 34,346.53 while the NASDAQ rose 0.75% to 14,556.92. The S&P also rose, gaining 1.18% to 4,358.52. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume... 
Via Benzinga
News headline image
Mid-Day Market Update: Dow Surges 300 Points; Omeros Shares Plummet ↗
Midway through trading Friday, the Dow traded up 0.88% to 34,141.74 while the NASDAQ rose 0.12% to 14,465.49. The S&P also rose, gaining 0.58% to 4,332.44. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Why Atea Pharmaceutical Stock Is Ripping Higher Today ↗
This biotech's experimental COVID-19 medication could be a big winner. 
Via The Motley Fool
News headline image
Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Rises In September ↗
Following the market opening Friday, the Dow traded up 0.49% to 34,010.27 while the NASDAQ fell 0.23% to 14,415.00. The S&P also rose, gaining 0.16% to 4,314.50. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Merck Stock Surges Into Buy Zone As Covid Pill Reduces Risk Of Death, Hospitalization ↗
Merck said its Covid pill, molnupiravir, cut the risk of death and hospitalization by half. 
Via Investor's Business Daily
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity... 
Via Benzinga
News headline image
48 Biggest Movers From Yesterday ↗
Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized... 
Via Benzinga
News headline image
Why Atea Pharmaceuticals Is Up 17% Today ↗
Orally administered treatments of COVID-19 infections are coming into focus as vaccine stocks lose their luster. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Atea Pharmaceuticals (NASDAQ:AVIR) shares increased by 13.83% to $29.86 during Monday's regular session. Trading volume for this security as of 12:30 EST is 3.... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company... 
Via Benzinga
News headline image
Atea Unveils Trial Amendments, New Data For COVID-19 Program ↗
Atea Pharmaceuticals Inc (NASDAQ: AVIR) has unveiled some changes to its AT-527 COVID-19 Phase 2 program to keep up with the "evolving COVID-19 environment.... 
Via Benzinga
News headline image
Atea Pharmaceuticals Inc (AVIR) Q2 2021 Earnings Call Transcript ↗
AVIR earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Biolase (NASDAQ:BIOL) shares mov... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE: 
Via Benzinga
News headline image
This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money ↗
An effective oral antiviral therapy for the coronavirus may be around the corner. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Alector (NASDAQ:ALEC) shares moved upwards by 52.47% to $34.17 during Friday's regular session. Alector's stock is trading at a volume of 26.9 million... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.